Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Trader makes $2.7 million with MAGA

Trader makes $2.7 million with MAGA

Bitget2024/05/27 07:14

Golden Finance reported that according to Lookonchain monitoring, a trader earned US$2.7 million by trading MAGA in just 3 days, with a return on investment as high as 505%. He spent US$537,500 on May 24 and May 25 to buy 6 billion MAGA, and then sold 1.5 billion MAGA 10 minutes ago, earning a profit of 744,000 USDT. He currently holds 4.5 billion MAGA, worth $2.51 million.

1
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

$40 billion in bond issuance with a maximum interest rate of 8.3%! SpaceX (SPCX.US) AI gamble also exposes the “funding winter” for AI infrastructure

According to media reports citing sources familiar with the matter, SpaceX is preparing to complete a debt issuance totaling $40 billion, with an interest rate significantly higher than previous borrowing costs, reflecting growing investor concerns over financing for artificial intelligence (AI) infrastructure.

智通财经•2026/10/23 01:02
$40 billion in bond issuance with a maximum interest rate of 8.3%! SpaceX (SPCX.US) AI gamble also exposes the “funding winter” for AI infrastructure

TS Lombard scenario analysis: An AI bubble burst could trigger a 30% plunge in the S&P 500, wiping out 20 trillion dollars in market value—but don't rush to short!

Dario Perkins from TS Lombard predicted in a scenario analysis released on Thursday that if AI capital expenditure collapses, approximately $20 trillions in U.S. stock market value could evaporate, triggering credit losses of $125 billions to $190 billions.

智通财经•2026/10/23 00:56

Gilead Sciences (GILD.US) acquires PepStar’s oral inflammation drug program for $1.275 billion in cash, increasing investment in inflammatory bowel disease pipeline

Gilead Sciences will acquire PepStar’s anti-inflammatory drug program for $1.28 billions.

智通财经•2026/10/23 00:37